Shopping Cart
- Remove All
- Your shopping cart is currently empty
TG2-179-1 is a BRCA1-associated protein 1 (BAP1) inhibitor with potential anticancer activity. TG2-179-1 exhibits potent cytotoxic activity against colon cancer cells and induces apoptosis. TG2-179-1 can be used in colon cancer research. TG2-179-1 is a BRCA1-associated protein 1 (BAP1) inhibitor with potential anticancer activity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $198 | 35 days | |
5 mg | $791 | 35 days | |
10 mg | $1,410 | 35 days |
Description | TG2-179-1 is a BRCA1-associated protein 1 (BAP1) inhibitor with potential anticancer activity. TG2-179-1 exhibits potent cytotoxic activity against colon cancer cells and induces apoptosis. TG2-179-1 can be used in colon cancer research. TG2-179-1 is a BRCA1-associated protein 1 (BAP1) inhibitor with potential anticancer activity. |
Molecular Weight | 484.95 |
Formula | C22H14ClFN4O2S2 |
Cas No. | 1135023-19-6 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||
Solubility Information | DMF: 1 mg/mL (2.06 mM), Sonication is recommended. Ethanol: 1 mg/mL (2.06 mM), Sonication is recommended. DMSO: 1 mg/mL (2.06 mM), Sonication is recommended. | ||||||||||
Solution Preparation Table | |||||||||||
DMF/Ethanol/DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.